Star Projects of #MEXC’s 0 Trading Fee Fest (Aug 22, 2025)!🏆 Top 3 Gainers:🏅 $PHA | @PhalaNetwork🥈 $AERO | @AerodromeFi🥉 $ENA | @ethena_labsNo trading fees, just pure gains!#MEXC0Fee ...

Core Insights - The article highlights the rapid development and innovation in China's synthetic biology sector, particularly focusing on Shanghai as a leading hub for synthetic biology initiatives and projects [2][3][4]. Group 1: Industry Development - Shanghai is recognized as the primary force in China's synthetic biology development, with significant milestones such as the establishment of the Chinese Academy of Sciences' synthetic biology laboratory in 2008 [2]. - In 2023, Shanghai released an action plan to accelerate synthetic biology innovation and build a high-end biomanufacturing industry cluster from 2023 to 2025 [2]. - The Shanghai Municipal Science and Technology Commission has initiated key projects in synthetic biology and computational biology to support rapid industry growth [2]. Group 2: Funding and Support - Shanghai has allocated substantial funding for synthetic biology projects, including 42 million yuan for 18 projects and 37 million yuan for 16 projects [3]. - The city has established industrial clusters in areas like Zhangjiang Science City and Lingang New Area, providing comprehensive support from research and development to pilot testing [3]. Group 3: Notable Companies - A total of 66 representative companies from Shanghai have been listed in the "China Biomanufacturing 500+ Representative Enterprises List" based on their team, core products, and competitive potential [4]. - Key companies in the synthetic biology sector include Kasei Biotech, Enkasei Pharmaceutical, and Changjin Biotech, all of which are located in the aforementioned industrial parks [3][4]. Group 4: Upcoming Events - The Fourth Synthetic Biology and Green Biomanufacturing Conference will be held from August 20-22, 2025, in Ningbo, Zhejiang, focusing on AI and biomanufacturing, green chemicals, new materials, future food, and agriculture [19][21]. - The conference aims to gather international enterprises, industry experts, and government representatives to explore trends and innovations in the biomanufacturing sector [19].

Core Viewpoint - The article emphasizes the importance of biomanufacturing as a key focus for enhancing economic competitiveness in various countries, including China, which is advancing its manufacturing capabilities through initiatives like green manufacturing and intelligent manufacturing [1]. Group 1: Event Overview - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI and biomanufacturing, along with four major application areas: green chemicals and new materials, future food, future agriculture, and beauty raw materials [1]. - The conference aims to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan period and identify innovative technologies and products that will sustain the industry's vitality [1]. Group 2: Organizing Institutions - The conference is organized by Ningbo Detaizhong Research Information Technology Co., Ltd. (DT New Materials) and co-organized by Ningbo Meisai Biological Engineering Co., Ltd. It is supported by various professional committees and alliances in the field of biomanufacturing [2]. Group 3: Highlights of the Conference - The conference will feature forums and closed-door activities to gain insights into the development trends of biomanufacturing, explore new products and technologies, and foster new collaborations [4]. - There will be over 100 financing project roadshows to discover new cooperation opportunities and showcase innovative technological achievements [4]. - Key industry leaders, top universities, capital from parks, and the entire industry chain will gather to discuss advancements and opportunities in biomanufacturing [4]. Group 4: Agenda and Activities - The first day will include a closed-door seminar focusing on the development trends and growth points of biomanufacturing during the 14th Five-Year Plan, inviting 30 industry leaders and experts for in-depth discussions [9]. - The second and third days will feature a macro forum on biomanufacturing, specialized sub-forums on green chemicals, AI in biomanufacturing, future food and agriculture, and beauty raw materials, addressing various key topics and innovations in these fields [13]. - A special session for showcasing scientific achievements and project matchmaking will also be held, inviting 100 innovative projects in the biomanufacturing sector for display and collaboration [14].

Core Viewpoint - The article emphasizes the importance of biomanufacturing as a key focus for enhancing economic competitiveness in various countries, including China, which is advancing its manufacturing capabilities through initiatives like green manufacturing and intelligent manufacturing [1]. Group 1: Event Overview - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI and biomanufacturing [1]. - The conference aims to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan and identify innovative technologies and products that will sustain the industry's vitality [1]. Group 2: Organizing Institutions - The conference is organized by Ningbo Detaizhong Research Information Technology Co., Ltd. (DT New Materials) and supported by various institutions, including the Chinese Society of Biotechnology and the Zhejiang Synthetic Biology Industry Technology Alliance [2]. Group 3: Conference Highlights - Key highlights include forums and closed-door discussions on biomanufacturing trends, youth innovation technology sharing, and over 100 financing project roadshows to discover new cooperation opportunities [4]. - The event will gather leading enterprises, top universities, investment institutions, and industry stakeholders to foster collaboration [4]. Group 4: Agenda and Activities - The first day features a closed-door seminar focusing on the development trends and growth points of biomanufacturing, inviting 30 industry leaders and experts for in-depth discussions [9]. - The second and third days will include a macro forum on biomanufacturing, specialized sub-forums on green chemicals, AI in biomanufacturing, future food and agriculture, and beauty raw materials [13]. Group 5: Specialized Topics - Sub-forums will cover various topics, including the development of bio-based chemicals, AI applications in enzyme discovery, and the biomanufacturing of high-value food ingredients [13]. - The conference will also showcase innovative projects and facilitate connections between research teams and industry players [12][14].

Core Viewpoint - The article emphasizes the importance of biomanufacturing as a key focus for enhancing economic competitiveness in various countries, including China, which is advancing its manufacturing capabilities through initiatives like green manufacturing and intelligent manufacturing [1]. Group 1: Event Overview - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI and biomanufacturing [1]. - The conference aims to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan, discussing innovative technologies and products that can sustain the industry's vitality [1]. Group 2: Organizing Institutions - The conference is organized by Ningbo Detai Zhongyan Information Technology Co., Ltd. (DT New Materials) and co-organized by Ningbo Meisai Biological Engineering Co., Ltd. [2]. - Supporting organizations include the Chinese Society of Biotechnology's Biobased Materials Committee and various local industry alliances [2]. Group 3: Highlights of the Conference - The conference will feature forums and closed-door activities to gain insights into the development trends of biomanufacturing and explore new products, technologies, and collaborations [5]. - There will be over 100 financing project roadshows to discover new cooperation opportunities [5]. - Key industry leaders, top universities, and investment institutions will gather to discuss advancements in the biomanufacturing sector [5]. Group 4: Agenda and Activities - The first day will include a closed-door seminar focusing on the development trends and growth points of biomanufacturing [10]. - The second and third days will feature a macro forum on biomanufacturing, specialized sub-forums on green chemicals, AI in biomanufacturing, future food and agriculture, and beauty raw materials [14]. - A special session for showcasing scientific achievements and project matchmaking will also be held, inviting innovative projects from the biomanufacturing field [15].

Core Viewpoint - The article discusses the innovative approach of Yike Biotech in reducing the cost of PHA (polyhydroxyalkanoates) production to compete with petroleum-based materials, emphasizing the use of non-food plant oils as raw materials [3][4][9]. Group 1: Industry Background - The biodegradable materials market, including PLA and PBAT, has faced challenges such as overcapacity and performance limitations, leading to a decline in production rates [6][7]. - PHA is highlighted for its advantages, including marine biodegradability, heat resistance up to 100°C, and excellent barrier properties, with the global market expected to reach $367 million by 2030 [6][8]. Group 2: Company Overview - Yike Biotech was founded in June 2025 by Dr. Wilson Ling, who aims to revolutionize PHA production using non-food oils, specifically Pongamia oil, to significantly lower costs [9][10]. - The company has completed laboratory and pilot-scale validations of its production process and is the first globally to hold a PCT patent for PHA production [37]. Group 3: Cost Reduction Strategy - The raw material cost constitutes over 50% of PHA production costs, making it essential to lower these costs. Traditional sugar-based routes have a conversion rate of only 30%, leading to high costs [27][28]. - By using Pongamia oil, which has a conversion rate of over 80%, Yike Biotech can reduce PHA production costs by 30-50% compared to sugar-based methods [36]. Group 4: Technical and Market Development - Yike Biotech plans to focus on medical products for the Australian market, where demand is high, and the approval process is faster compared to other regions [38]. - The company aims to establish a production line in China that can replace 15,000 to 20,000 tons of petroleum-based plastics annually, with plans for further expansion [39].

Core Viewpoint - The article emphasizes the importance of biomanufacturing as a key focus for enhancing economic competitiveness in various countries, including China, which is advancing its manufacturing capabilities through initiatives like green manufacturing and intelligent manufacturing [1]. Group 1: Event Overview - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynBioCon 2025) will be held from August 20-22 in Ningbo, Zhejiang, focusing on the integration of AI and biomanufacturing [1]. - The conference aims to explore the development trends of the biomanufacturing industry during the "14th Five-Year Plan" period, discussing innovative technologies and products that can sustain the industry's vitality [1]. Group 2: Organizers and Highlights - The conference is organized by Ningbo Detaizhong Research Information Technology Co., Ltd. (DT New Materials) and co-organized by Ningbo Meisai Biological Engineering Co., Ltd. [2]. - Key highlights include forums on biomanufacturing trends, youth innovation sharing, project roadshows, and participation from leading enterprises, top universities, and investment institutions [4]. Group 3: Agenda and Special Activities - The first day features a closed-door high-level seminar focusing on biomanufacturing development trends and growth points, inviting 30 industry leaders and experts [7]. - The second and third days will include a macro forum on biomanufacturing, specialized sub-forums on green chemicals, AI in biomanufacturing, future food and agriculture, and beauty raw materials [11]. Group 4: Focus Areas in Sub-Forums - Sub-forum topics include the development of bio-based chemicals, green manufacturing technologies for fine chemicals, and the use of non-food raw materials for high-value product development [11]. - AI applications in biomanufacturing will also be discussed, including the use of AI for enzyme discovery and industrial fermentation process control [11].

Core Viewpoint - The article discusses the innovative approach of Ecopha Biotech, founded by Dr. Wilson Ling, to significantly reduce the cost of PHA (polyhydroxyalkanoates) production by utilizing non-food plant oils, specifically Pongamia oil, as a raw material, aiming to compete with traditional petroleum-based plastics [2][9][31]. Group 1: Industry Background - The biodegradable materials market, including PLA and PBAT, has faced challenges such as oversupply and performance limitations, leading to a decline in production rates [6][7]. - PHA stands out due to its advantages like "biomanufacturing," "marine biodegradability," and high thermal resistance (up to 100°C), with the global market expected to reach $367 million by 2030 [6][9]. - The current cost of PHA exceeds 40,000 yuan per ton, making it difficult to compete with petroleum-based plastics priced below 10,000 yuan per ton [7][9]. Group 2: Company Background - Ecopha Biotech was established in June 2025, with Dr. Wilson Ling returning to China after years of research and entrepreneurship abroad, driven by the desire to overcome the cost barriers of PHA production [9][19]. - The company aims to leverage a patented strain of bacteria and non-food oils to achieve a significant reduction in production costs [9][22]. Group 3: Raw Material Cost Reduction - The primary focus for cost reduction is on raw materials, which account for over 50% of PHA production costs. Traditional sugar-based routes have a conversion rate capped at 30%, leading to high costs [22][23]. - Dr. Ling's research determined that using plant oils, particularly Pongamia oil, could achieve a conversion rate of over 80%, significantly lowering production costs [22][31]. - Pongamia oil is non-food, cost-effective (half the price of palm oil), and has a high yield, making it suitable for sustainable production [25][30][31]. Group 4: Technological Advancements - Ecopha Biotech has completed laboratory and pilot-scale validations for using Pongamia oil and has designed a process package for a large-scale production line [32]. - The company plans to focus on medical products initially, targeting the Australian market, where there is a high demand for biodegradable medical supplies [33]. - The first production line in China is expected to replace 15,000 to 20,000 tons of petroleum-based plastics annually once operational [33]. Group 5: Future Outlook - Dr. Ling envisions that the real competition for PHA is not other bioplastics but the vast quantities of petroleum-based plastics that contribute to environmental pollution [34]. - The company aims to collaborate with domestic peers to promote the large-scale industrialization of PHA, potentially alleviating plastic pollution issues as production scales up [34].

【DT新材料】 获 悉， 近日，Teknor Apex（特诺尔爱佩斯）宣布完成对 Danimer Scientific, Inc.的收购，后者是 当前美国知名PHA企业， 收购价格仅为1900万美元 。 Danimer 成立于 2004 年，最初以 PLA（聚乳酸）改性加工业务为主。通过多次技术收购（如 2007 年宝洁技术、2021 年 Novomer 热催化工艺专利）和产能扩张（如肯塔基州工厂年产能达 2000 万磅 Nodax® PHA），成为当前美国产能最大、应用最广的 PHA 生产商之一，其 使用菜籽油作为主要原 料 。 关键订单取消 ：2024年星巴克突然终止餐具供应协议，导致PHA销售额单季度下降180万美元，直接切断核 心现金流。 欧洲市场萎缩+原料价格上涨 ： 俄乌战争推高菜籽油（PHA原料）价格30% ，叠加物流成本上升，欧洲客 户PLA订单减少240万美元，毛利率进一步恶化。 图片来源：Danimer Danimer 总部位于美国乔治亚州班布里奇市，拥有两处基地，总面积超 20 万平方英尺，包括世界级实验 室、生产基地及检测中心。 该公司在 20 多个国家拥有 480 多项授权专利和正在 ...

Core Viewpoint - The article discusses the intensifying global competition for carbon neutrality and how the bio-based industry can address three major contradictions: reliance on upstream raw materials, certification barriers in the midstream, and limitations in downstream applications [1]. Group 1: Event Overview - The 2025 Bio-based Industry Strategic Seminar was held from May 25-27 in Shanghai, focusing on industry breakthroughs [3]. - The seminar gathered 25 representatives from industry associations, well-known brands, material companies, and research institutions to discuss three core topics: market reshaping, policy collaboration, and technological breakthroughs [6]. Group 2: Key Insights from the Seminar - **Need for Certification and Traceability**: International brand representatives emphasized that non-food bio-based raw material certification (C14 testing + supply chain traceability) has become a prerequisite for collaboration [10]. - **Price Tolerance**: Brands are generally willing to accept a price increase of up to 10%, but a doubling of costs would hinder promotion [11]. - **Performance and Application**: Companies highlighted the need for bio-based materials to meet specific performance requirements, such as lightweight and decorative features for automotive parts, and integrated packaging solutions for cosmetics [12][14]. Group 3: Strategies for Bio-based Material Companies - **Cost and Purity Challenges**: The bio-based furan industry is focusing on overcoming the cost and purity challenges of FDCA, which is currently priced at 40 times that of PTA [14]. - **Identifying Unique Value Propositions**: Companies agreed that bio-based materials should leverage unique performance advantages rather than merely replacing petroleum-based materials [15]. - **Policy Collaboration**: There is a call for China to establish a bio-based material standard system in conjunction with the EU's packaging regulations to facilitate non-food raw material development [16]. Group 4: AI Empowerment in Bio-manufacturing - Companies shared practices of using AI to reduce R&D costs by 30% through protein modification, enhancing enzyme efficiency, and improving accuracy and speed in research [16]. Group 5: Regional Development Initiatives - Zhoushan is positioning itself as a new hub for the bio-based industry by attracting projects related to PLA, PHA, FDCA-PEF, and providing comprehensive support including raw material supply and industrial land [17]. Group 6: Consensus and Conclusions - The seminar reached three core conclusions: 1. Upstream raw materials must shift to non-food sources for large-scale commercialization, driven by policy and technological innovation [20]. 2. Accelerating the establishment of carbon footprint standards aligned with international norms is essential to break down green trade barriers [20]. 3. Collaboration between brands and material suppliers is necessary to redefine applications from "performance substitution" to "value creation" [20].